Life Sciences
Data from University Medical Center, Division of Pediatric Hematology advance knowledge in life sciences in children
Published in Pain and Central Nervous System Week, March 22nd, 2010
Scientists discuss in 'Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group' new findings in life sciences. "Poor outcome in Stage 4 neuroblastoma may be improved with increased dose intensity of therapy. We investigated the feasibility of sequential collection and infusion of peripheral blood stem cells (PBSCs) as hematopoietic support for non-myeloablative dose intensive induction chemotherapy given every 21-28 days," researchers in the United States report.
"Twenty-two children with Stage 4 neuroblastoma...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
More Articles from Pain and Central Nervous System Week
- American Academy of Neurology
Years of smoking associated with lower Parkinson's risk, not number of cigarettes per day - Columbia University Medical Center
Acupuncture may relieve joint pain caused by some breast cancer treatments - Cooney Waters Group, Inc.
Study reinforces role of AED Vimpat lacosamide C-V as add-on treatment for POS - Duke University Medical Center
New methods needed to ID cardiac catheterization candidates - Elsevier Health Sciences
Is prenatal screening for rare diseases like spinal muscular atrophy too costly? - Research Australia
Snake venom charms science world - More from this issue of Pain and Central Nervous System Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
